FDA.reportPublic FDA data

TAZVERIK 200 MG Oral Tablet

RxCUI
2274390
RxNorm name
TAZVERIK 200 MG Oral Tablet
Display name
TAZVERIK 200 MG Oral Tablet
Full name
TAZVERIK 200 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TAZVERIKTAZEMETOSTATEpizyme, Inc.7db07b5f-4e22-467c-9c0a-f830b08dbb1d2026-04-29Warnings, Adverse reactionsExact identifier
rxcui: 2274390

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7db07b5f-4e22-467c-9c0a-f830b08dbb1dTAZVERIK 200 MG Oral Tablet [PSN] · tazemetostat 200 MG Oral Tablet [Tazverik] [SBD] · Tazverik 200 MG (equivalent to 228 MG tazemetostat HBr) Oral Tablet [SY] · Tazverik 200 MG Oral Tablet [SY]49These highlights do not include all the information needed to use TAZVERIK ® safely and effectively. See full prescribing information for TAZVERIK. TAZVERIK (tazemetostat) tablets, for oral use Initial U.S. Approval: 202020260429